Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-amplification process

Clinical Cancer Research

Volumn 13, Issue 17, 2007, Pages 4974-4983

  Hoshi, Kanako ^a,d   Takakura, Hideki ^a,d   Mitani, Yasumasa ^a,b   Tatsumi, Kenji ^a,d   Momiyama, Nobuyoshi ^d   Ichikawa, Yasushi ^d   Togo, Shinji ^d   Miyagi, Toru ^f   Kawai, Yuki ^a,b   Kogo, Yasushi ^a   Kikuchi, Takeshi ^a,b   Kato, Chiaki ^a,b   Arakawa, Takahiro ^a   Uno, Syuji ^a,c   Cizdziel, Paul E ^a   Lezhava, Alexander ^a   Ogawa, Noburou ^e   Hayashizaki, Yoshihide ^a,c   Shimada, Hiroshi ^d  

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b KK DNAFORM ^*

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital   (Japan)

^f WAKUNAGA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; GENOMIC DNA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; GENETICS; GENOTYPE; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MUTATION; NUCLEIC ACID AMPLIFICATION; TUMOR CELL LINE;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EXONS; FEMALE; GENE DELETION; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 34548813643     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0509     Document Type: Article

References (26)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43.
2. Cohen MH, Williams GA, Sridhara R, et al. United States Food and Drug Administration drug approval summary: Gefitinib (ZD1839;Iressa) tablets. Clin Cancer Res 2004;10:1212-8.
3. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-500.
4. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non - small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
5. Marchetti A, Martella C, Felicioni L, et al. EGFR mutations in non - small-cell lung cancer:analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol 2005;23:857-65.
6. Pan Q, Pao W, Ladanyi M. Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas. J Mol Diagn 2005;7:396-403.
7. Endo K, Konishi A, Sasaki H, et al. Epidermal growth factor receptor gene mutation in non - small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer 2005;50:375-84.
8. Sasaki H, Endo K, Konishi A, et al. EGFR mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler. Clin Cancer Res 2005;11:2924-9.
9. Nagai Y, Miyazawa H, Huqun, et al. Genetic heterogeneity of the epidermal growth factor receptor in non - small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 2005;65:7276-82.
10. Asano H, Toyooka S, Tokumo M, et al. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay. Clin Cancer Res 2006;12:43-8.
11. Kimura H, Kazuo K, Makoto K, et al. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non - small-cell lung cancer. Clin Cancer Res 2006;12:3915-21.
12. Zhou C, Zhao Y, Su B. Rapid detection of epidermal growth factor receptor mutations in non - small cell lung cancer using real-time polymerase chain reaction with TaqMan-MGB probes. Cancer J 2006;12:33-9.
13. Oshita F, Matsukuma S, Yoshihara M, et al. Novel heteroduplex method using small cytology specimens with a remarkably high success rate for analysing EGFR gene mutations with a significant correlation to gefitinib efficacy in non - small-cell lung cancer. Br J Cancer 2006;95:1070-5.
14. Ohnishi H, Ohtsuka K, Ooide A, et al. A simple and sensitive method for detecting major mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene in non - small-cell lung carcinoma. Diagn Mol Pathol 2006 ;15:101-8.
15. Thomas RK, Nickersion E, Simons JF, et al. Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reacter sequencing. Nat Med 2006;12:852-5.
16. Janne PA, Borras AM, Kuang Y, et al. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Clin Cancer Res 2006;12:751-8.
17. Willmore-Payne C, Holden JA, Layfield LJ. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcimona by high-resolution meltiong amplicon analysis:correlation with gene copy number, protein expression, and hormone receptor expression. Hum Pathol 2006;37:755-63.
18. Maruyama K, Takeyama H, Mori T, et al. Detection of epidermal growth factor receptor (EGFR) mutations in non - small cell lung cancer (NSCLC) using a fully automated system with a nano-scale engineer biomagnetite. Biosens Bioelectron 2006.
19. Mitani Y, Alexander Lezhava, Kawai Y, et al. Rapid SNP diagnostic using asymmetric isothermal amplification and a new mismatch-supression technology. Nature Methods. In press 2007.
20. Wagner R, Debbie P, Radman M. Mutation detection using immobilized mismatch binding protein (MutS). Nucleic Acids Res 1995;23:3944-8.
21. Whitehouse A, Deeble J, Parmar R, Taylor RG, Markham FA, Meredith MD. Analysis of the mismatch and insertion/deletion binding properties of Thermus thermophilus, HB8, MutS. Biochem Biophys Res Commun 1997;233:834-7.
22. Levine A J, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453-6.
23. Gansauge S, Gansauge F, Beger HG. Molecular oncology in pancreatic cancer. J Mol Med 1996;9:1-11.
24. Goldblum JR. Gastrointestinal stromal tumors. A review of characteristics morphologic, immunohistochemical, and molecular genetic features. Am J Clin Pathol 2002;117:49-61.
25. Christopher LC, Jonathan AF, Michael CH. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004;22:3813-25.
26. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.